Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

492 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    China's First Unwinding Order: SAMR Blocks Completed Below-Threshold Pharma Deal

    On 23 July 2025, China's State Administration for Market Regulation (SAMR) issued a prohibition decision against Wuhan Yongtong Pharmaceutical's (YT Pharma) acquisition of Shandong...
    ChinaAntitrust/Competition Law
    Herbert Smith Freehills Kramer LLP
    Herbert Smith Freehills Kramer LLP
  • Article

    What Are China's Merger Review Priorities?

    China's merger control regime has been a topic of discussion for some time now. Some commentators interpret Chinese merger control as being influenced by political factors; namely, more than encourage competition...
    ChinaAntitrust/Competition Law
    AnJie Broad Law Firm
    AnJie Broad Law Firm
  • Article

    中企出海法律合规系列——印度尼西亚经营者集中申报十问十答

    印度尼西亚施行的是事后强制申报制度。交易完成后30个工作日内需要向印度尼西亚反垄断执法机构("KPPU")提交申报。
    ChinaAntitrust/Competition Law
    AnJie Broad Law Firm
    AnJie Broad Law Firm
  • Article

    当特朗普先生遇上反垄断

    本文通过对前述三次"交锋"的简要分析,以试图窥探如特朗普先生成功当选总统后对反垄断执法所可能持有的态度。
    ChinaAntitrust/Competition Law
    Dentons
    Dentons
  • Article

    Equity Investment From United Kingdom Into China

    Agreements to transfer shares in a PRC company are typically subject to PRC stamp duty at a rate of 0.05% of the consideration, which applies to both the purchaser and the seller.
    ChinaCorporate/Commercial Law
    King & Wood Mallesons
    King & Wood Mallesons
  • Article

    Equity Investment From US Into China

    Agreements to transfer shares in a PRC company are typically subject to PRC stamp duty at a rate of 0.05% of the consideration, which applies to both the purchaser and the seller.
    ChinaCorporate/Commercial Law
    King & Wood Mallesons
    King & Wood Mallesons
  • Article

    《上市公司重大资产重组管理办法》新法修订要点解析与实务影响

    2025年5月16日,中国证监会正式发布修订后的《上市公司重大资产重组管理办法》(下称"《重组办法》或新规"),
    ChinaCorporate/Commercial Law
    AnJie Broad Law Firm
    AnJie Broad Law Firm
  • Article

    China Offers New Possibilities For Drug License Transfers

    The Chinese pharmaceutical market is experiencing double-digit growth and will become the world’s second-largest market after the United States by 2016, according to IMS Health.
    ChinaFood, Drugs, Healthcare, Life Sciences
    Ropes & Gray LLP
    Ropes & Gray LLP
  • Article

    China Offshore - October 2015

    Welcome to our second report on China's Foreign Direct Investment (FDI) and outbound mergers and acquisitions (M&A) activity.
    ChinaWealth Management
    Appleby
    Appleby
  • Article

    Choosing Outside Counsel: A Former General Counsel’s Perspective

    Having spent a significant part of my career as an in-house lawyer with multinational companies—including Shell, Hershey Foods, Dole Food Company and Nissan North America—I have had the opportunity to experience the attorney-client relationship from both sides of the table.
    ChinaCorporate/Commercial Law
    IPO Pang P.C.
    IPO Pang P.C.
  • Article

    保险资金投资保险类企业:从双重监管到合并审查的路径统一

    双重监管属性使得此类投资行为面临程序衔接与审批标准协调的现实挑战,亟需从制度层面厘清监管路径。
    ChinaInsurance
    AnJie Broad Law Firm
    AnJie Broad Law Firm
  • Article

    Merger Control In 2013

    There were some interesting twists in the public and private enforcement of China’s Anti-Monopoly Law (AML) during 2013.
    ChinaAntitrust/Competition Law
    Mayer Brown
    Mayer Brown
  • Article

    Validity Of Pre-IPO VAM Agreements In China

    A secret pre-IPO agreement containing a valuation adjustment mechanism (VAM) has been declared invalid by the Shanghai High People's Court lately, arousing concerns...
    ChinaCorporate/Commercial Law
    Jingtian & Gongcheng
    Jingtian & Gongcheng
  • Article

    Shanghai QFLP private equity fund rules released at last - 17 January 2011

    One of the main restrictions on private equity in China is being removed in Shanghai. Foreign private equity investors will be able to form limited partnership RMB funds, and qualified foreign limited partners ("QFLP") will be able to invest with RMB converted from foreign currency.
    ChinaFinance and Banking
    King & Wood Mallesons
    King & Wood Mallesons
  • Article

    China's Foreign Investment Law——New Rules And Their Impacts

    Foreign direct investment of China has been ranking No. one among developing countries for twenty-seven consecutive years, according to reports of the United Nations Conference on Trade and Development.
    ChinaGovernment, Public Sector
    DeHeng Law Offices
    DeHeng Law Offices
  • Article

    A Practical Guide: How To Really Make China's SCC Work For Your Business

    Article 38 of the Personal Information Protection Law stipulates four compliance paths for the cross-border transfer of personal information, namely:
    ChinaMedia, Telecoms, IT, Entertainment
    Zhong Lun Law Firm
    Zhong Lun Law Firm
  • Article

    《私募股权投资基金大看台》系列文章之一 如何快速搞懂私募股权投资基金

    随着科创板注册制改革与创业板存量注册制改革双双顺利落地,以及《证券法》修订后正式施行,资本市场令人惊喜地给了不少优秀创业企业&
    ChinaFinance and Banking
    AnJie Broad Law Firm
    AnJie Broad Law Firm
  • Article

    New Chinese Anti-Monopoly Law

    China's National People's Congress ("NPC") finally adopted a new Anti-Monopoly Law ("AML") in August after more than 10 years of drafting. The law will take effect on August 1, 2008. The new AML is a tremendous leap forward for China, bringing it squarely into the modern world of antitrust and competition law. Based loosely on various European models and input from U.S. law
    ChinaAntitrust/Competition Law
    Jones Day
    Jones Day
  • Article

    Filing-based System For Overseas Listing (V) – Investors

    For a long time, overseas listing of domestic enterprises has been one of the major ways for investment institutions to exit. The filing-based system for overseas offering and listing adopts...
    ChinaCorporate/Commercial Law
    Han Kun Law Offices
    Han Kun Law Offices
  • Article

    险资不动产基金投资实务

    随着中国证券投资基金业协会于2023年2月发布《不动产私募投资基金试点备案指引(试行)》("4号文"),不动产基金在基金以及保险等领域又收!
    ChinaFinance and Banking
    AnJie Broad Law Firm
    AnJie Broad Law Firm
  • Showing 321–340 of 492 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics